Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141107 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2024-05-09 | 2024-09-19 | 227471 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174601 |
| TEVA-CARVEDILOL | 12.5MG | TABLET | Resolved | 2020-06-04 | 2020-09-25 | 116687 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-05-09 | 2024-09-19 | 227474 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109586 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-06-26 | 2024-01-11 | 196406 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2019-11-21 | 2020-01-30 | 99426 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-09 | 190716 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-08-05 | 2021-12-02 | 143716 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173049 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-03-12 | 2020-04-02 | 108590 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124980 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2022-10-28 | 2023-10-03 | 173007 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-10-30 | 2020-11-12 | 127610 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195885 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-06 | 195894 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128013 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-01-24 | 2020-04-09 | 104356 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2020-01-17 | 2020-04-02 | 103572 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |